UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Scientific advice
Prevention and control of communicable diseases in prison settings.
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Update 2021; Immunization, Vaccines and Biologicals
54th directing council; 67th session of the regional Committee of WHO for the Americas
CD54/11, Rev. 1, 2 October 2015, Original: Spanish
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...fic to preventing transmission of Mycobacterium tuberculosis bridging with the core components of infection prevention and control programmes at the national and acute health care facility level
more
The Lancet Global Health January 24, 2022
A survival guide for clinicans.
3rd edition.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326